HME Business

  • Home
  • Topics
    • COVID-19
    • Accreditation
    • Competitive Bidding
    • DME Pharmacy
    • Legislative
    • Mobility
    • Oxygen
    • Pain Management
    • Retail
    • Sales and Marketing
    • Sleep Therapy
    • Software/IT
  • News
  • Resources
    • Whitepapers
    • Buyers Guide
    • DME Associations
  • Podcasts
  • Request Media Kit
  • Webinars
  • Digital Edition
  • Events
  • Awards
  • Advertise
  • Subscribe

Respironics’ Sleep Diagnostics Group Earns Frost & Sullivan Award

July 1, 2006 by HME Business

MURRYSVILLE, Pa. &#151 Respironics Inc. was awarded the 2006 Frost & Sullivan Market Leadership Award in the sleep diagnostic device market based on the company’s continued market leadership, strategic advancement, technology innovation and ability to adapt.


According to Frost & Sullivan (a global growth consulting company), the award acknowledges Respironics’ market leadership in the sleep diagnostics segment and is given to the company that exhibits market share leadership through the implementation of market strategy.


“We are extremely pleased with this honor and it is a reflection of the talent, dedication and efforts of our entire engineering, plant services, field sales and product support teams,” says Ron Fligge, global product manager, Sleep Diagnostics, Respironics. “I believe our growth in sleep diagnostics is due to our expanding portfolio of solutions that includes the Alice&reg5 Sleep System, Alice&reg Sleepware&reg Software, Stardust&regII Sleep Recorder, new interactive training tools and accessory options,” Fligge adds.


To choose the recipient of the award, Frost & Sullivan analysts track competitor revenue and market share within the industry. This is achieved through interviews with all market participants and extensive secondary research of proprietary data sources. Frost & Sullivan compares the rankings for relative position and presents the award to the company that receives the number one industry rank.


In addition, award recipients are chosen based on one or more of the following criteria: market share, revenue growth rates, profitability, and market and technology innovation.

Related Articles Read More >

Temporary Restraining Order Reinstates BOC as Accrediting Organization
The reinstatement is effective Jan. 9, 2025.
Fisher & Paykel’s F&P Nova Nasal Mask Now Available in US
The new mask is designed to support easy fitting and sound sleep for sleep apnea patients.
‘Common Sense’ Home Infusion Reform Discussed at Congressional Subcommittee Hearing
NHIA CEO Connie Sullivan urged House members to support the Preserving Patient Access to Home Infusion Act.
AAHomecare CEO to Congressional Subcommittee: ‘We Believe 37% of the Industry Has Gone Out of Business’
Tom Ryan testified about three durable medical equipment bills on Jan. 8.

Get the free newsletter

Home Healthcare Softare

Subscribe to HME Business for industry & product news, trends and resources.
HME Business Directory
HME Podcasts
HME Business
  • Mobility Management
  • Senior Housing News
  • Home Health Care News
  • Skilled Nursing News
  • Hospice News
  • Behavioral Health Business
  • About HME Business
  • Contact Us

Copyright © 2026 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search HME Business

  • Home
  • Topics
    • COVID-19
    • Accreditation
    • Competitive Bidding
    • DME Pharmacy
    • Legislative
    • Mobility
    • Oxygen
    • Pain Management
    • Retail
    • Sales and Marketing
    • Sleep Therapy
    • Software/IT
  • News
  • Resources
    • Whitepapers
    • Buyers Guide
    • DME Associations
  • Podcasts
  • Request Media Kit
  • Webinars
  • Digital Edition
  • Events
  • Awards
  • Advertise
  • Subscribe